LACTO-N-FUCOPENTAOSE I

LACTO-N-FUCOPENTAOSE I Struktur
7578-25-8
CAS-Nr.
7578-25-8
Englisch Name:
LACTO-N-FUCOPENTAOSE I
Synonyma:
LNF I;LNF-1;LNFP I;IV2FUC-LCOSE4;LACTO-N-FUCOPENTAOSE I;LACTO-N-FUCOPENTAOSE-1;Lacto-N-fucopentaose Ⅰ;Lacto-N-fucopentaose I (LNFP I);Fucα1,2Galβ1,3GlcNAcβ1,3Galβ1,4Glc;Lacto-N-neofucopentaose I (LnNFP-I)
CBNumber:
CB5763416
Summenformel:
C32H55NO25
Molgewicht:
853.77
MOL-Datei:
7578-25-8.mol

LACTO-N-FUCOPENTAOSE I Eigenschaften

storage temp. 
2-8°C

Sicherheit

Kennzeichnung gefährlicher B
R-Sätze: 20/21/22-37/38-41
S-Sätze: 26-36/37/39-24/25
WGK Germany  3
10-21
HS Code  29400090

LACTO-N-FUCOPENTAOSE I Chemische Eigenschaften,Einsatz,Produktion Methoden

R-Sätze Betriebsanweisung:

R20/21/22:Gesundheitsschädlich beim Einatmen,Verschlucken und Berührung mit der Haut.
R37/38:Reizt die Atmungsorgane und die Haut.
R41:Gefahr ernster Augenschäden.

S-Sätze Betriebsanweisung:

S26:Bei Berührung mit den Augen sofort gründlich mit Wasser abspülen und Arzt konsultieren.
S36/37/39:Bei der Arbeit geeignete Schutzkleidung,Schutzhandschuhe und Schutzbrille/Gesichtsschutz tragen.

Chemische Eigenschaften

White solid

Verwenden

LNF-1 human milk saccharide, contains blood group O (H) type I determinant

Definition

ChEBI: A linear amino pentasaccharide comprising one fucose, two galactose, one glucosamine and one glucose unit (at the reducing end), linked as shown.

LACTO-N-FUCOPENTAOSE I Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


LACTO-N-FUCOPENTAOSE I Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 48)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
BOC Sciences
+1-631-485-4226
inquiry@bocsci.com United States 19553 58
TargetMol Chemicals Inc.
+1-781-999-5354
support@targetmol.com United States 19973 58
ShenZhen Trendseen Biological Technology Co.,Ltd.
13417589054
trendseenbio@gmail.com China 11681 58
J & K SCIENTIFIC LTD. 010-82848833 400-666-7788
jkinfo@jkchemical.com China 96815 76
Hunan Hui Bai Shi Biotechnology Co., Ltd. 0731-85526065 13308475853
ivy@hnhbsj.com China 4550 62
ChemStrong Scientific Co.,Ltd 0755-0755-66853366 13670046396
sales@chem-strong.com China 17993 56
Sichuan Wei Keqi Biological Technology Co., Ltd. 028-81700200 18116577057
3003855609@qq.com China 7892 56
Chengdu Push Bio-Technology Co., Ltd. 028-85370565-229 18080489829
3004654993@qq.com China 9176 60
Beijing Minruida Technology Co., Ltd. 010-82387566 18001021521;
sales@mreda.com.cn China 21450 58
Shenzhen Polymeri Biochemical Technology Co., Ltd. +86-400-002-6226 13028896684
sales@rrkchem.com China 55936 58

7578-25-8()Verwandte Suche:


  • LNF-1
  • LNF I
  • LNFP I
  • LACTO-N-FUCOPENTAOSE-1
  • LACTO-N-FUCOPENTAOSE I
  • IV2FUC-LCOSE4
  • LACTO-N-FUCOPENTAOSE I FROM HUMAN MILK
  • α-l-fuc (1→2)-β-d-gal-(1→3)-β-d-glcnac-(1→3)-β-d-gal-(1→4)-d-glc
  • N-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[(2R,3S,4R,5R)-6-hydroxy-1-oxo-2,4-bis[[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]-5-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyhexan-3-yl]oxyoxan-3-yl]acetamide
  • LNFP I, α-L-Fuc (1-2)-β-D-Gal-(1-3)-β-D-GlcNAc-(1-3)-β-D-Gal-(1-4)-D-Glc
  • Lacto-N-fucopentaose I (LNFP I)
  • alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp
  • Lacto-N-fucopentaose Ⅰ
  • ALPHA-L-FUC [1->2]-BETA-D-GAL-[1->3]-BETA-D-GLCNAC-[1->3]-BETA-D-GAL-[1->4]-D-GLC
  • N-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3R,4R,5R)-1,2,4,5-tetrahydroxy-6-oxohexan-3-yl]oxyoxan-4-yl]oxy-4-[(2R,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
  • Lacto-N-neofucopentaose I (LnNFP-I)
  • Blood group H antigen pentaose type 1 / Lacto-N-fucopentaose I (LNFP I)
  • D-Glucose, O-6-deoxy-α-L-galactopyranosyl-(1→2)-O-β-D-galactopyranosyl-(1→3)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-
  • Fuc-a-1,2-Gal-b-1,3-GlcNAc-b-1,3-Gal-b-1,4-Glc
  • Fucα1,2Galβ1,3GlcNAcβ1,3Galβ1,4Glc
  • Blood group O(H) type I determinant
  • D-Glucose, O-6-deoxy-α-L-galactopyranosyl-(1→2)-O-β-D-galactopyranosyl-(1→3)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-
  • 7578-25-8
  • Carbohydrate Standards
  • Carbohydrate Analysis
  • Carbohydrates
  • BioChemical
  • Biochemicals and Reagents
  • Post-translational Modification
  • Proteomics
  • P to Q
  • Proteomics and Protein Expression
  • Proteasome inhibitor
  • Disaccharide
  • D to K
  • Enzyme Inhibitors
  • Enzyme Inhibitors by Enzyme
  • Enzymes, Inhibitors, and Substrates
  • Guanylate cyclase
Copyright 2019 © ChemicalBook. All rights reserved